论文部分内容阅读
目的:针对胆汁反流性胃炎患者采用铝碳酸镁与西沙比利的方法进行治疗,并探究分析其用药的效果。方法:选择84例胆汁反流性胃炎患者作为本次的观察对象,均在2014年5月至2015年5月期间在本院接受治疗,根据随机数字表的方法将其分成试验组与对照组,各42例患者,试验组口服西沙比利与铝碳酸镁,对照组服用铝碳酸镁,对比两组患者用药后的临床效果。结果:试验组治疗后的各症状计分情况明显少于对照组的,且试验组的胆汁反流次数与总时间情况明显优于对照组的,其差异具有统计学意义(P<0.05)。结论:胆汁反流性胃炎患者服用铝碳酸镁加用西沙必利治疗的疗效相比于单一药物在一定程度上具有明显的优势,建议广泛使用。
Objective: To treat patients with bile reflux gastritis by the method of hydrotalcite and cisapride, and to explore the effect of its medication. Methods: Eighty-four patients with bile reflux gastritis were selected as the observation subjects and were treated in our hospital from May 2014 to May 2015. According to the method of random number table, they were divided into experimental group and control group , Each of 42 patients, test group oral cisapride and magnesium aluminum carbonate, the control group taking aluminum magnesium carbonate, the clinical efficacy of the two groups were compared. Results: The score of each symptom after treatment in the experimental group was significantly less than that in the control group, and the times and total time of bile reflux in the experimental group were significantly better than those in the control group (P <0.05). CONCLUSIONS: The therapeutic effect of taking magnesium aluminum carbonate plus cisapride in patients with bile reflux gastritis is better than that of single drug. It is suggested that it should be widely used.